TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.